lymphatic endothelial cells Search Results


96
PromoCell primary human dermal microvascular lymphatic endothelial cells
Primary Human Dermal Microvascular Lymphatic Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human dermal microvascular lymphatic endothelial cells/product/PromoCell
Average 96 stars, based on 1 article reviews
primary human dermal microvascular lymphatic endothelial cells - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

90
Cell Applications Inc primary human dermal lymphatic microvascular endothelial cells hdlmvecs
Primary Human Dermal Lymphatic Microvascular Endothelial Cells Hdlmvecs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human dermal lymphatic microvascular endothelial cells hdlmvecs/product/Cell Applications Inc
Average 90 stars, based on 1 article reviews
primary human dermal lymphatic microvascular endothelial cells hdlmvecs - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Rockland Immunochemicals secondary antibodies against cd31
Secondary Antibodies Against Cd31, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/secondary antibodies against cd31/product/Rockland Immunochemicals
Average 90 stars, based on 1 article reviews
secondary antibodies against cd31 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

94
PromoCell lentivirus transduction human dermal lymphatic endothelial cells hdlec
Lentivirus Transduction Human Dermal Lymphatic Endothelial Cells Hdlec, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lentivirus transduction human dermal lymphatic endothelial cells hdlec/product/PromoCell
Average 94 stars, based on 1 article reviews
lentivirus transduction human dermal lymphatic endothelial cells hdlec - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

97
Lonza human lymphatic endothelial cells hlecs
Inhibitory effects of platelets <t>on</t> <t>endothelial</t> cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of <t>hLECs</t> (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).
Human Lymphatic Endothelial Cells Hlecs, supplied by Lonza, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lymphatic endothelial cells hlecs/product/Lonza
Average 97 stars, based on 1 article reviews
human lymphatic endothelial cells hlecs - by Bioz Stars, 2026-06
97/100 stars
  Buy from Supplier

90
Boster Bio lyve 1
Inhibitory effects of platelets <t>on</t> <t>endothelial</t> cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of <t>hLECs</t> (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).
Lyve 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lyve 1/product/Boster Bio
Average 90 stars, based on 1 article reviews
lyve 1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

94
Angio-Proteomie human pulmonary lymphatic microvascular endothelial cells
Inhibitory effects of platelets <t>on</t> <t>endothelial</t> cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of <t>hLECs</t> (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).
Human Pulmonary Lymphatic Microvascular Endothelial Cells, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human pulmonary lymphatic microvascular endothelial cells/product/Angio-Proteomie
Average 94 stars, based on 1 article reviews
human pulmonary lymphatic microvascular endothelial cells - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

94
Angio-Proteomie primary human hepatic lymphatic endothelial cells
Inhibitory effects of platelets <t>on</t> <t>endothelial</t> cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of <t>hLECs</t> (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).
Primary Human Hepatic Lymphatic Endothelial Cells, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human hepatic lymphatic endothelial cells/product/Angio-Proteomie
Average 94 stars, based on 1 article reviews
primary human hepatic lymphatic endothelial cells - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

90
Innoprot Inc human ln endothelial cells hlec innoprot
Inhibitory effects of platelets <t>on</t> <t>endothelial</t> cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of <t>hLECs</t> (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).
Human Ln Endothelial Cells Hlec Innoprot, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ln endothelial cells hlec innoprot/product/Innoprot Inc
Average 90 stars, based on 1 article reviews
human ln endothelial cells hlec innoprot - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AngioBio Inc human neonatal dermal lymphatic endothelial cells
Inhibitory effects of platelets <t>on</t> <t>endothelial</t> cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of <t>hLECs</t> (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).
Human Neonatal Dermal Lymphatic Endothelial Cells, supplied by AngioBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human neonatal dermal lymphatic endothelial cells/product/AngioBio Inc
Average 90 stars, based on 1 article reviews
human neonatal dermal lymphatic endothelial cells - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Lonza cloneticstm dermal lymphatic microvascular endothelial cells (lecs)
Timeline of in vitro wound healing model. The culture-insert is first attached to a well plate. The supporting cells, human dermal fibroblasts (HDFs) and mesenchymal stem cells (MSCs), are cultured inside for 9 days in either the MSC-HDF or HDF-HDF configuration. In MSC-HDF, the supporting cells alternate between MSCs and HDFs, whereas HDF-HDF only contain HDFs. Subsequently, lymphatic <t>endothelial</t> cells <t>(LECs)</t> are seeded on top for 10 h of vessel assembly, or lymphangiogenesis, before culture-insert removal. Three inserts were used for each configuration at each imaging timepoint.
Cloneticstm Dermal Lymphatic Microvascular Endothelial Cells (Lecs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cloneticstm dermal lymphatic microvascular endothelial cells (lecs)/product/Lonza
Average 90 stars, based on 1 article reviews
cloneticstm dermal lymphatic microvascular endothelial cells (lecs) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Lonza human dermal lymphatic microvascular endothelial cells
Timeline of in vitro wound healing model. The culture-insert is first attached to a well plate. The supporting cells, human dermal fibroblasts (HDFs) and mesenchymal stem cells (MSCs), are cultured inside for 9 days in either the MSC-HDF or HDF-HDF configuration. In MSC-HDF, the supporting cells alternate between MSCs and HDFs, whereas HDF-HDF only contain HDFs. Subsequently, lymphatic <t>endothelial</t> cells <t>(LECs)</t> are seeded on top for 10 h of vessel assembly, or lymphangiogenesis, before culture-insert removal. Three inserts were used for each configuration at each imaging timepoint.
Human Dermal Lymphatic Microvascular Endothelial Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human dermal lymphatic microvascular endothelial cells/product/Lonza
Average 90 stars, based on 1 article reviews
human dermal lymphatic microvascular endothelial cells - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Inhibitory effects of platelets on endothelial cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of hLECs (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).

Journal: The Journal of Biological Chemistry

Article Title: Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells *

doi: 10.1074/jbc.M111.329987

Figure Lengend Snippet: Inhibitory effects of platelets on endothelial cell proliferation. Platelets inhibited hLEC proliferation but not HUVEC proliferation, depending on CLEC-2. A, cell proliferation of hLECs (upper panels) and HUVECs (lower panels) in the presence of buffer (left panels) and hPlt (right panels, 1 × 108/ml) was investigated by thymidine analog incorporation assay. A group of EdU-incorporated cells is indicated by arrows. B and C, cell proliferation of hLECs (B) and HUVECs (C) in the presence of buffer, hPlt (1 × 108/ml), mPlt WT (1 × 108/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 108/ml) was investigated by thymidine analog incorporation assay. Quantification of the proliferation was performed as described under “Experimental Procedures.” The graph illustrates percent change ± S.E. from base line (buffer) (n = 10 from four independent experiments).

Article Snippet: Cells Human umbilical vein endothelial cells (HUVECs) and human lymphatic endothelial cells (hLECs) were purchased from Lonza (Basel, Switzerland) and maintained on culture dishes in endothelial growth medium-2 (EGM-2; Lonza) supplemented with 5% FBS and an EGM-2 microvascular set (0.5 ml of human EGF, 0.2 ml of hydrocortone, 25 ml of FBS, 0.5 ml of VEGF, 2 ml of human FGF-B, 0.5 ml of R3-IGF-1, 0.5 ml of ascorbic acid, and 0.5 ml of GA-1000).

Techniques:

Inhibitory effects of platelets on tube formation of endothelial cells through CLEC-2. A and B, tube formation of hLECs (4 × 105/ml) (A) or HUVECs (5 × 105/ml) (B) in the presence (hPlt) or absence (buffer) of human washed platelets (1 × 108/ml). Images are representative of five different experiments. C, quantification of tube formation. D, tube formation of mLECs (1.25 × 105/ml) in the presence of buffer, wild-type mPlt WT (1 × 107/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 107/ml). Images are representative of three different experiments. E, quantification of mLEC tube formation. The graphs in C and E show quantification of tube formation as percent change ± S.E. from base line (buffer) (n = 10–12 from three independent experiments). Three asterisks denote p < 0.005.

Journal: The Journal of Biological Chemistry

Article Title: Platelet Activation Receptor CLEC-2 Regulates Blood/Lymphatic Vessel Separation by Inhibiting Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells *

doi: 10.1074/jbc.M111.329987

Figure Lengend Snippet: Inhibitory effects of platelets on tube formation of endothelial cells through CLEC-2. A and B, tube formation of hLECs (4 × 105/ml) (A) or HUVECs (5 × 105/ml) (B) in the presence (hPlt) or absence (buffer) of human washed platelets (1 × 108/ml). Images are representative of five different experiments. C, quantification of tube formation. D, tube formation of mLECs (1.25 × 105/ml) in the presence of buffer, wild-type mPlt WT (1 × 107/ml), and CLEC-2-deficient murine washed platelets (mPlt KO, 1 × 107/ml). Images are representative of three different experiments. E, quantification of mLEC tube formation. The graphs in C and E show quantification of tube formation as percent change ± S.E. from base line (buffer) (n = 10–12 from three independent experiments). Three asterisks denote p < 0.005.

Article Snippet: Cells Human umbilical vein endothelial cells (HUVECs) and human lymphatic endothelial cells (hLECs) were purchased from Lonza (Basel, Switzerland) and maintained on culture dishes in endothelial growth medium-2 (EGM-2; Lonza) supplemented with 5% FBS and an EGM-2 microvascular set (0.5 ml of human EGF, 0.2 ml of hydrocortone, 25 ml of FBS, 0.5 ml of VEGF, 2 ml of human FGF-B, 0.5 ml of R3-IGF-1, 0.5 ml of ascorbic acid, and 0.5 ml of GA-1000).

Techniques:

Timeline of in vitro wound healing model. The culture-insert is first attached to a well plate. The supporting cells, human dermal fibroblasts (HDFs) and mesenchymal stem cells (MSCs), are cultured inside for 9 days in either the MSC-HDF or HDF-HDF configuration. In MSC-HDF, the supporting cells alternate between MSCs and HDFs, whereas HDF-HDF only contain HDFs. Subsequently, lymphatic endothelial cells (LECs) are seeded on top for 10 h of vessel assembly, or lymphangiogenesis, before culture-insert removal. Three inserts were used for each configuration at each imaging timepoint.

Journal: Bioengineering

Article Title: Fibroblast-Generated Extracellular Matrix Guides Anastomosis during Wound Healing in an Engineered Lymphatic Skin Flap

doi: 10.3390/bioengineering10020149

Figure Lengend Snippet: Timeline of in vitro wound healing model. The culture-insert is first attached to a well plate. The supporting cells, human dermal fibroblasts (HDFs) and mesenchymal stem cells (MSCs), are cultured inside for 9 days in either the MSC-HDF or HDF-HDF configuration. In MSC-HDF, the supporting cells alternate between MSCs and HDFs, whereas HDF-HDF only contain HDFs. Subsequently, lymphatic endothelial cells (LECs) are seeded on top for 10 h of vessel assembly, or lymphangiogenesis, before culture-insert removal. Three inserts were used for each configuration at each imaging timepoint.

Article Snippet: CloneticsTM Dermal Lymphatic Microvascular Endothelial Cells (LECs) and Poietics TM Normal Human Bone Marrow Derived Mesenchymal Stem Cells (MSCs) were obtained from Lonza, Basel, Switzerland.

Techniques: In Vitro, Cell Culture, Imaging

Engineered lymphatic flap and wound healing model. ( A ) Composition of engineered lymphatic flap. The three layers of the engineered flap (lymphatic capillaries, MSCs, and HDF extracellular matrix (ECM)) mimics the ultra-thin skin flaps used in vascularized lymph vessel transfer (VLVT). ( B ) Mechanism of bilayered wound healing assay. Capillary formation and sprouting is limited by the basal ECM. Supporting cell proliferation and ECM secretion allows lymphangiogenesis over the inhospitable culture plate substrate. ( C ) Immunostaining of engineered flap. LECs (Red). Collagen I (Green). Cell Nuclei (Blue). Scale bar: 100 µm. ( D ) Natural collagen swirls forming in the process of wound healing. Lymphatic capillaries colocalized with these ECM patterns. Wound gaps with detached tissues were excluded for analysis. LECs (red) Collagen I (Green). Wound gap: 500 µm. Scale bar: 13 mm.

Journal: Bioengineering

Article Title: Fibroblast-Generated Extracellular Matrix Guides Anastomosis during Wound Healing in an Engineered Lymphatic Skin Flap

doi: 10.3390/bioengineering10020149

Figure Lengend Snippet: Engineered lymphatic flap and wound healing model. ( A ) Composition of engineered lymphatic flap. The three layers of the engineered flap (lymphatic capillaries, MSCs, and HDF extracellular matrix (ECM)) mimics the ultra-thin skin flaps used in vascularized lymph vessel transfer (VLVT). ( B ) Mechanism of bilayered wound healing assay. Capillary formation and sprouting is limited by the basal ECM. Supporting cell proliferation and ECM secretion allows lymphangiogenesis over the inhospitable culture plate substrate. ( C ) Immunostaining of engineered flap. LECs (Red). Collagen I (Green). Cell Nuclei (Blue). Scale bar: 100 µm. ( D ) Natural collagen swirls forming in the process of wound healing. Lymphatic capillaries colocalized with these ECM patterns. Wound gaps with detached tissues were excluded for analysis. LECs (red) Collagen I (Green). Wound gap: 500 µm. Scale bar: 13 mm.

Article Snippet: CloneticsTM Dermal Lymphatic Microvascular Endothelial Cells (LECs) and Poietics TM Normal Human Bone Marrow Derived Mesenchymal Stem Cells (MSCs) were obtained from Lonza, Basel, Switzerland.

Techniques: Wound Healing Assay, Immunostaining

Images of capillary invasion into the wound gap after a 48-h lymphangiogenic period. ( A , B ) Day 4. Supporting cells have closed the wound gap. Some capillaries have formed, but not yet invaded the wound gap. Capillaries were still short and immature. ( C ) LECs fail to form capillaries when seeded directly on the culture dish. Capillary invasion over wound gaps must therefore be over basal cells. ( D – G ) Day 8. Capillaries have invaded the wound gap. MSC-HDF gaps had more connecting capillaries than HDF-HDF. Scale bar: 500 µm.

Journal: Bioengineering

Article Title: Fibroblast-Generated Extracellular Matrix Guides Anastomosis during Wound Healing in an Engineered Lymphatic Skin Flap

doi: 10.3390/bioengineering10020149

Figure Lengend Snippet: Images of capillary invasion into the wound gap after a 48-h lymphangiogenic period. ( A , B ) Day 4. Supporting cells have closed the wound gap. Some capillaries have formed, but not yet invaded the wound gap. Capillaries were still short and immature. ( C ) LECs fail to form capillaries when seeded directly on the culture dish. Capillary invasion over wound gaps must therefore be over basal cells. ( D – G ) Day 8. Capillaries have invaded the wound gap. MSC-HDF gaps had more connecting capillaries than HDF-HDF. Scale bar: 500 µm.

Article Snippet: CloneticsTM Dermal Lymphatic Microvascular Endothelial Cells (LECs) and Poietics TM Normal Human Bone Marrow Derived Mesenchymal Stem Cells (MSCs) were obtained from Lonza, Basel, Switzerland.

Techniques:

Fibroblasts guide capillary integration through natural collagen I alignment during in vitro graft integration. ( A ) ECM-mediated anastomosis model, where end-to-end anastomosis of capillaries from opposing wound edges are guided by collagen tracks. ( B – D ) Fibroblast proliferation and migration patterns in the wound gap leave behind collagen tracks that the capillaries follow. Arrows mark the direction of the collagen fibers as well as capillary invasion. LECs (red) Collagen I (Green). Scale bar: 200 µm.

Journal: Bioengineering

Article Title: Fibroblast-Generated Extracellular Matrix Guides Anastomosis during Wound Healing in an Engineered Lymphatic Skin Flap

doi: 10.3390/bioengineering10020149

Figure Lengend Snippet: Fibroblasts guide capillary integration through natural collagen I alignment during in vitro graft integration. ( A ) ECM-mediated anastomosis model, where end-to-end anastomosis of capillaries from opposing wound edges are guided by collagen tracks. ( B – D ) Fibroblast proliferation and migration patterns in the wound gap leave behind collagen tracks that the capillaries follow. Arrows mark the direction of the collagen fibers as well as capillary invasion. LECs (red) Collagen I (Green). Scale bar: 200 µm.

Article Snippet: CloneticsTM Dermal Lymphatic Microvascular Endothelial Cells (LECs) and Poietics TM Normal Human Bone Marrow Derived Mesenchymal Stem Cells (MSCs) were obtained from Lonza, Basel, Switzerland.

Techniques: In Vitro, Migration

Immunostaining of implanted engineered lymphatic flap. Rat-human chimeric capillaries were found 7 days after subcutaneous implantation in athymic nude rats ( n = 3). Rat, Human PDPN (green), HNA (red). Each row represents a different site of anastomosis. Arrows point to HNA - LECs within HNA + vessels. Scale bar: 50 µm.

Journal: Bioengineering

Article Title: Fibroblast-Generated Extracellular Matrix Guides Anastomosis during Wound Healing in an Engineered Lymphatic Skin Flap

doi: 10.3390/bioengineering10020149

Figure Lengend Snippet: Immunostaining of implanted engineered lymphatic flap. Rat-human chimeric capillaries were found 7 days after subcutaneous implantation in athymic nude rats ( n = 3). Rat, Human PDPN (green), HNA (red). Each row represents a different site of anastomosis. Arrows point to HNA - LECs within HNA + vessels. Scale bar: 50 µm.

Article Snippet: CloneticsTM Dermal Lymphatic Microvascular Endothelial Cells (LECs) and Poietics TM Normal Human Bone Marrow Derived Mesenchymal Stem Cells (MSCs) were obtained from Lonza, Basel, Switzerland.

Techniques: Immunostaining